Library
Staff-written explainers on peptide science. Comment or suggest an edit on any article.Oral GLP-1 Absorption: Why It Changed Metabolic Research
Peptides are famously hard to give by mouth because the gut breaks them down. Getting a GLP-1 analog absorbed orally was a real pharmacology milestone. Why it mattered, and where it led.
UpdatedHow Peptide Research Moved From Niche to Mainstream
Ten years ago peptides were confined to specialist journals and a few labs; now they're a headline topic. What changed: clearer biology, better manufacturing, and per-batch documentation.
UpdatedGLP-1 Compounds and Mitochondrial Peptides: The Case for Studying Them Together
Incretin agonists work through hormonal signaling, while mitochondrial-derived peptides act on cellular energy. Some research looks at both as separate controls on one metabolic system. A conceptual overview.
UpdatedThe Move From Single-Target to Multi-Receptor Metabolic Compounds
Metabolic research has shifted from compounds aimed at one receptor to molecules that act on two or three. A plain look at the reasoning behind dual and triple incretin agonists, plus where the approved drugs stand.
UpdatedHow Recovery, Metabolism and Longevity Research Share the Same Mechanisms
Tissue repair, metabolic and aging research used to be separate topics. Today they keep pointing at the same biology: blood-vessel growth, mitochondrial signaling and growth-factor pathways.
UpdatedHow Healthy Aging Became a Central Research Question
Aging research moved from asking how long we live to how long we stay healthy, the idea of healthspan. Why that shift put cellular energy and repair at the center.
UpdatedTen Research Areas That Keep Coming Up in Performance and Recovery Peptide Studies
A tour of the recovery and performance research areas that appear most often in the peptide literature: what gets studied, in which models, and which compounds are tied to each.
UpdatedHow Recovery Became a Research Field of Its Own
Recovery research went from an afterthought to a focus in its own right. Why repair-associated peptides such as BPC-157 and TB-500 helped drive that change.
UpdatedVisceral Fat in Peptide Research: Why Abdominal Fat Gets So Much Attention
Visceral adipose tissue, the active fat around the abdominal organs, is studied as a separate endpoint from subcutaneous fat. Why it draws research interest, what the tesamorelin trials showed, and how incretin data fit in.
UpdatedHow Clinical Studies Describe GLP-1 Tolerability and Dose-Related Effects
The incretin literature reports effects that rise with dose and are mostly gastrointestinal. How published clinical research describes tolerability, offered only as scientific context and not as dosing guidance.
UpdatedCopper Peptides in Skin Research: What the GHK-Cu Literature Covers
Skin is a popular model for peptide research because it is accessible, measurable and full of tissue-remodeling biology. What the literature looks at, with the copper peptide GHK-Cu as the main example.
UpdatedPeptide Not Giving the Expected Result? Variables to Check First
When a research peptide does not give the result you expected, the cause is usually one of a few controllable variables rather than the compound itself. A step-by-step troubleshooting checklist.
UpdatedIs a More Expensive Peptide Actually Higher Quality?
Price and quality measure different things. A high price does not promise purity and a low one does not mean junk. What really sets quality, and how to check it from the paperwork.
UpdatedL-Carnitine: Fatty-Acid Transport and Energy Metabolism Research
L-carnitine carries long-chain fatty acids into mitochondria so they can be used for energy. What the bioenergetics research covers and why it sits alongside peptide topics.
UpdatedRetatrutide: Research on a Triple GLP-1/GIP/Glucagon Agonist
Retatrutide acts on three receptors: GLP-1, GIP and glucagon. It is an investigational compound studied in clinical trials. The mechanism and the research so far.
UpdatedPeptide Blends or Single Peptides: Which Fits Your Study?
Blends put compounds with complementary pathways in one vial. Single peptides test one variable at a time. Neither is better overall; they answer different questions.
UpdatedNAD+ Research: Energy Metabolism, Sirtuins and Aging
NAD+ is a coenzyme at the heart of energy metabolism, DNA repair and the sirtuin pathways studied in aging research. Why it became such a central molecule in longevity science.
UpdatedDSIP: Research on the Delta-Sleep-Inducing Peptide
DSIP is a nine-amino-acid neuropeptide named for its link to delta-wave sleep. Decades later its mechanism is still not settled. A summary of the main reviews.
UpdatedTesamorelin Research: A GHRH Analog and the GH/IGF-1 Axis
Tesamorelin is a GHRH analog, FDA-approved in 2010 as Egrifta for HIV-associated lipodystrophy. How it acts on the GH/IGF-1 axis and what the clinical trial record shows.
UpdatedMOTS-c Research: A Peptide Encoded in Mitochondrial DNA
MOTS-c is a mitochondrial-derived peptide studied for metabolic balance, AMPK signaling, and biology linked to exercise and aging. A plain-language overview of the research so far.
UpdatedSermorelin and GHRH(1-29): A Research Overview
Sermorelin is GHRH(1-29), the shortest piece of growth-hormone-releasing hormone that keeps the full activity of the native hormone. It was once an FDA-approved drug. Here is what the research covers.
UpdatedTirzepatide: How a Dual GIP/GLP-1 Agonist Is Studied
Tirzepatide activates both the GIP and GLP-1 receptors and is an FDA-approved drug (Mounjaro, Zepbound). The mechanism, the main trials, and what that record does and doesn't mean for research material.
UpdatedCJC-1295: Research on a Long-Acting GHRH Analog
CJC-1295 is a modified GHRH analog built to last longer in circulation, studied for extended growth-hormone and IGF-1 signaling. The research background in brief.
UpdatedGHK-Cu Research: The Copper Tripeptide and Tissue Remodeling
GHK-Cu, a tripeptide that binds copper, is studied for skin regeneration, collagen-related signaling and antioxidant effects. An overview of the research from Pickart's early work on.
UpdatedIpamorelin: What the Research Says About a Selective Ghrelin-Receptor Agonist
Ipamorelin is a small synthetic peptide that acts on the ghrelin receptor (GHS-R1a) and was reported as the first growth-hormone secretagogue selective for GH release. A look at the key papers.
UpdatedSemaglutide: GLP-1 Receptor Research and Trial Record
Semaglutide is a long-acting GLP-1 receptor agonist, FDA-approved as Ozempic, Rybelsus and Wegovy. How it was developed, the oral form, and the STEP trial.
UpdatedTB-500 Research: A Thymosin β4 Fragment in Cell Migration Studies
TB-500 is a short synthetic fragment derived from thymosin β4, an actin-binding protein. Preclinical work uses it to study cell migration, angiogenesis and tissue-repair signaling.
UpdatedBPC-157 Research: Gut Protection, Blood Vessel Growth and Soft Tissue
BPC-157 is a stable 15-amino-acid gastric peptide and among the most studied compounds in preclinical repair research. A plain summary of what the animal and in-vitro work reports.
UpdatedPeptide Handling Errors That Ruin Vials, and How Labs Prevent Them
Plenty of ruined research peptides were fine when they arrived and were damaged by handling. The usual errors that degrade a vial, and the simple habits labs use to avoid each one.
UpdatedBacteriostatic Water or DMSO? Picking a Solvent for Peptide Stocks
Most research peptides dissolve fine in bacteriostatic water; a few poorly soluble ones need a co-solvent such as DMSO. How labs choose between them, and what each means for handling.
UpdatedFreeze-Dried Powder or Ready-Made Liquid: Choosing a Peptide Form
Research peptides nearly always arrive as freeze-dried powder rather than liquid, and stability is the reason. How lyophilized and pre-mixed forms compare on shelf life, shipping and convenience.
UpdatedReading a Peptide COA: What HPLC Purity and Mass Spec Tell You
Purity and identity answer different questions, and a solid certificate of analysis covers both. How to read one, what a ≥99% HPLC figure really measures, and the warning signs.
UpdatedStoring Research Peptides: Temperature, Freeze-Thaw and Shelf Life
Careless temperature control, light exposure and repeated freeze-thaw all degrade peptides without any visible sign. A practical cold-storage rundown for powder and solution.
UpdatedReconstituting Lyophilized Peptides: The Math and the Method
Turning a freeze-dried peptide into a usable solution comes down to one division and a gentle hand. The concentration math, the bench steps, and the errors that waste a vial.
UpdatedBefore Asking About Doses: Why Research Basics Come First
The question new people ask most is about dosing, and it's the wrong starting point. Why identity, purity, handling and study design come first in RUO peptide work.
UpdatedResearch Peptides Explained in Plain Language
A peptide is a short chain of amino acids, and in the lab synthetic ones serve as reference compounds. What that means, how a peptide's identity is pinned down, and why the paperwork counts.
Updated